Strengthening the response to XDR-TB in India: A call for enhanced diagnostics and treatment strategies

References

1. Global Tuberculosis Report 2024 [Internet]. Geneva; 2024 Nov [cited 2025 Jan 1]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb- reports/global-tuberculosis-report-2024
2. Kherabi Y, Pedersen OS, Lange C, Kharkiv U. Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study “Regional Phtisiopulmonological Center” of the Kharkiv Regional Council, Communal Non-commercial Enterprise. Lancet Reg Health - Eur [Internet]. 2025;56:101380.
3. Singla R, Khan S, Silsarma A, Chavan V, Mahajan R, Mansoor H, et al. Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study. Clin Infect Dis. 2025:ciaf068.
4. Intermediate Reference Laboratories [IRL] and their role | Knowledge Base [Internet]. [cited 2025 Sep 2]. Available from: https://ntep.in/node/1846/CP-intermediate-reference-laboratories- irl-and-their-role
5. India has 1,15,900 MBBS seats across 780 Medical Colleges: Health Ministry gives breakup [Internet]. [cited 2025 Sep 5]. Available from: https://medicaldialogues.in/news/education/india- has-115900-mbbs-seats-across-780-medical-colleges-health- ministry-gives-breakup-152854
6. Mishra GP, Mulani J. Implications of bedaquiline-resistant tuberculosis. Lancet Infect Dis [Internet]. 2022;22(2):166.
7. Mishra G. Therapeutic drug monitoring: The future of tuberculosis management. IP Indian J Immunol Respir Med [Internet]. 2022;7(1):1–3.
8. ICMR. National Essential Diagnostics List, 2025 [Internet]. 2nd ed. Walia K, Vijay S, editors. New Delhi: Division of Descriptive Research, Indian Council of Medical Research; 2025 [cited 2025 Aug 6]. 25 p. Available from: https://www.icmr.gov.in/icmrobject/uploads/Report/1752588650_n edl2ndedition.pdf
9. Munje R, Chawla R, Chetambath R, Christopher DJ, Dhar R, Ghoshal AG, et al. Position statement of the Indian Chest Society on reinstatement of the Respiratory Medicine department in undergraduate medical colleges in India. Lung India [Internet]. 2023;40(6):487.
10. Mishra GP, Gandhi SA, Ghorpade S V. Study of Various Causes of Treatment Interruption Among Tuberculosis Patients. Indian J Basic Appl Med Res. 2016;6(1):382–6.
11. Curry International Tuberculosis Center. Tuberculosis Infection Control: A Practical Manual for Preventing TB [Internet]. Second Edition. 2024 [cited 2025 Sep 5]. Available from: https://www.currytbcenter.ucsf.edu/sites/default/files/2024- 07/IC_2024_ONLINE.pdf
12. Ministry of Health and Family Welfare, Government of India. Guidelines for Programmatic Management of Tuberculosis Preventive Treatment in India. 2021;123. [cited 2025 Aug 6]. Available from: https://tbcindia.mohfw.gov.in/wp- content/uploads/2023/05/Guidelines-for-Programmatic- Management-of-Tuberculosis-Preventive-Treatment-in-India.pdf
13. Mishra G, Mulani J. Latent Multi-drug Resistant Tuberculosis: An Unaddressed Problem. Arch Pulmonol Respir Care [Internet]. 2020;6(1):084–6.
14. Mishra GP. Public-private mix in tuberculosis. Lancet Infect Dis [Internet]. 2012;12(12):908–9.